Live updates

Advertisement

Union to ballot 3,000 Sellafield workers for strike action

The strike ballot begins on Monday, 14th August 2017 Credit: PA

GMB, the union for nuclear workers, is balloting 3,000 members at Sellafield for strike action after the company ignored requests for further talks and said it would put in place a below-inflation pay offer.

Sellafield offered 1.5% in June which was rejected by 88% of GMB members on site during a consultative ballot. The Unite union is also balloting its 2,000 members at Sellafield.

The strike ballot begins on Monday, 14 August 2017 and will close on Monday, 4 September 2017.

Advertisement

Tim Farron: GSK should leave 'dowry' for site's future investment and jobs

GSK pulled out of a planned £350million investment in the Ulverston site Credit: GSK

South Lakeland MP Tim Farron has called for pharmaceutical company GlaxoSmithKline (GSK) to leave a dowry behind to make future investment in the site more attractive for a potential buyer and to support local jobs.

This week GSK shocked the area by pulling out of a planned £350million investment in the Ulverston site which would have supported hundreds of local jobs.

Tim Farron says the local community is still reeling from the news:

People feel betrayed and many residents are understandably concerned about the impact on jobs. GSK should commit to leaving a substantial dowry of several million pounds, to show good faith to the local community.

Leaving even a fraction of the £350million that GSK would have invested would help to support local jobs and partially compensate local residents for this blow. Our local community has shown deep commitment to GSK. GSK must now show an ongoing commitment to our community. Anything else will be an appalling betrayal.”

– Tim Farron, South Lakeland MP

South Lakes council 'shocked' at GlaxoSmithKline's Ulverston investment back out

GSK will no longer be investing in its Ulverston site Credit: GSK

South Lakeland District Council (SLDC) say they are 'shocked and disappointed' at pharmaceutical giant, GlaxoSmithKine's (GSK) decision to pull out its investment from its Ulverston site in Cumbria.

SLDC’s portfolio holder for the economy, Councillor Graham Vincent, said the news was a blow. He said the council's concern now is to understand the implications for the future of the current site and the existing GSK employees in Ulverston.

The SLDC's chief executive spoke to GSK management who have said there will be no immediate impact on the existing workforce and the site does remain profitable. The council have said they will assist the company in finding a buyer, to continue the operation of the facility, should they decide to sell up.

We have been in meetings and discussions with GSK in the last few weeks about unrelated matters and there was no suggestion that this announcement was on the horizon. We will work with the company, the local MP, town, county and district councillors and Cumbria LEP to offer whatever support is necessary.

– Councillor Graham Vincent, South Lakes District Council Economy Portfolio Holder
Load more updates